Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake

Hypertension

Volumn 61, Issue 5, 2013, Pages 1002-1007

  Nakajima, Hideto ^a   Ishida, Tatsuro ^a   Satomi Kobayashi, Seimi ^a   Mori, Kenta ^a   Hara, Tetsuya ^a   Sasaki, Naoto ^a   Yasuda, Tomoyuki ^a   Toh, Ryuji ^a   Tanaka, Hidekazu ^a   Kawai, Hiroya ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

endothelial lipase; fatty acids; heart failure; high density lipoprotein; inflammation

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FATTY ACID OXIDATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC DYSFUNCTION; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY ACIDS; HEART FAILURE; HYPERTENSION; LIPASE; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84876688777     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.201608     Document Type: Article

References (27)

1. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279-293.
2. Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab. 2003;284:E331-E339.
3. Ballard FB, Danforth WH, Naegle S, Bing RJ. Myocardial metabolism of fatty acids. J Clin Invest. 1960;39:717-723.
4. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet. 1999;21:424-428.
5. Hirata K, Dichek HL, Cioff JA, Choi SY, Leeper NJ, Quintana L, Kronmal GS, Cooper AD, Quertermous T. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem. 1999;274:14170-14175.
6. Rader DJ, Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr Opin Lipidol. 2000;11:141-147.
7. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res. 2002;43:921-929.
8. Jin W, Sun GS, Marchadier D, Octtaviani E, Glick JM, Rader DJ. Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res. 2003;92:644-650.
9. Kratky D, Zimmermann R, Wagner EM, Strauss JG, Jin W, Kostner GM, Haemmerle G, Rader DJ, Zechner R. Endothelial lipase provides an alternative pathway for FFA uptake in lipoprotein lipase-defcient mouse adipose tissue. J Clin Invest. 2005;115:161-167.
10. Kojma Y, Hirata K, Ishida T, Shimokawa Y, Inoue N, Kawashima S, Quertermous T, Yokoyama M. Endothelial lipase modulates monocyte adhesion to the vessel wall. A potential role in infammation. J Biol Chem. 2004;279:54032- 54038.
11. Shimokawa Y, Hirata K, Ishida T, Kojima Y, Inoue N, Quertermous T, Yokoyama M. Increased expression of endothelial lipase in rat models of hypertension. Cardiovasc Res. 2005;66:594-600.
12. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch WJ, Koch W; American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology. Animal models of heart failure: a scientifc statement from the American Heart Association. Circ Res. 2012;111:131-150.
13. Steinbusch LK, Luiken JJ, Vlasblom R, Chabowski A, Hoebers NT, Coumans WA, Vroegrijk IO, Voshol PJ, Ouwens DM, Glatz JF, Diamant M. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab. 2011;301:E618-E627.
14. Hirata K, Ishida T, Matsushita H, Tsao PS, Quertermous T. Regulated expression of endothelial cell-derived lipase. Biochem Biophys Res Commun. 2000;272:90-93.
15. Braun JE, Severson DL. Regulation of the synthesis, processing and trans-location of lipoprotein lipase. Biochem J. 1992;287 (pt 2):337-347.
16. Feingold KR, Marshall M, Gulli R, Moser AH, Grunfeld C. Effect of endo-toxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb. 1994;14:1866-1872.
17. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838-1842.
18. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
19. Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apoli-poproteins. J Lipid Res. 1989;30:39-49.
20. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837-2842.
21. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem. 1998;273:29530- 29539.
22. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α. Proc Natl Acad Sci USA. 2006;103:10086-10091.
23. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'armiento J, Abel ED, Goldberg IJ. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem. 2006;281:8716-8723.
24. Nohara R. Lipid metabolism in the heart-contribution of BMIPP to the diseased heart. Ann Nucl Med. 2001;15:403-409.
25. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem. 2000;43:527-550.
26. Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J. High-density lipoprotein hydrolysis by endothelial lipase activates PPARα: a candidate mechanism for high-density lipoprotein-medi-ated repression of leukocyte adhesion. Circ Res. 2006;98:490-498.
27. Hara T, Ishida T, Kojima Y, Tanaka H, Yasuda T, Shinohara M, Toh R, Hirata K. Targeted deletion of endothelial lipase increases HDL particles with anti-infammatory properties both in vitro and in vivo. J Lipid Res. 2011;52:57-67.